1. Novel therapies targeted at signal transduction in liver tumors;Abou-Alfa,2004
2. Phase II study of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in patients with advanced hepatocellular carcinoma (HCC). Fourth International Meeting on Hepatocellular Carcinoma: Eastern and Western Experiences, Hong Kong;Abou-Alfa;Asian J Surg,2004
3. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study;Baker;Cancer Treat Reports,1977
4. Carcinome hépatocellulaire sur cirrhose: traitement par la Doxorubicine. Essai phase II;Barbare;Bull Cancer,1984
5. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging;Barentsz;Radiology,1998